You are not logged in. Only partial content from the Question of the Day will be available to you. To view the full content of this Question of the Day, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.
The Development and Evolution of the Cannabis Dispensary
Throughout this week, we have been discussing the development and evolution of cannabis dispensaries in the United States. We will end this week by examining the trends of medical cannabis use across the country.
Editors' Note: Medical marijuana has become an important area of study in healthcare. Doctors and healthcare professionals must understand the medical, legal, social and political issues to best respond to their patients’ questions and attend to their needs. This content area is not intended to encourage or dissuade the use of medical marijuana, but has been created to provide a balanced portrayal of the research in this area. The Drug Enforcement Agency issued “The DEA Position on Marijuana” in January 2011, which is their most recent position statement and provides information about medical marijuana and issues related to the conflicts between federal and state law.
Data from Israel show that in August 2011, 6,000 patients received medicinal cannabis (0.8 patients per 1,000 citizens). It is estimated that the number will increase to 40,000 in 2016 (5.2 patients per 1,000 citizens).
In Canada 12,116 patients were allowed to use cannabis in September 2011 (0.35 patients per 1,000 citizens).
The numbers of patients using cannabis from the pharmacies in the Netherlands were estimated to be 1,300 in 2010 (0.08 patients per 1,000 citizens). However, many patients in the Netherlands use cannabis from the coffee shops or grow their own.
In Germany, only about 60 patients are currently allowed to use cannabis for medicinal purposes.